Effect of green tea supplementation on blood pressure among overweight and obese adults: a systematic review and meta-analysis
- PMID: 25479028
- DOI: 10.1097/HJH.0000000000000426
Effect of green tea supplementation on blood pressure among overweight and obese adults: a systematic review and meta-analysis
Abstract
Background: Emerging randomized controlled trials (RCTs) investigating the effect of green tea or green tea extract (GTE) supplementation on blood pressure (BP) among overweight and obese adults reported inconsistent findings.
Objective: To conduct a systematic review and meta-analysis to clarify the efficacy of green tea or GTE on BP among overweight and obese adults.
Methods: Electronic databases, conference proceedings and gray literature were searched systematically to include parallel and cross-over RCTs examining the efficacy of green tea or GTE on BP compared with placebo. Data were meta-analyzed using a random-effects model, to compare the mean difference of the change in BP from baseline in the intervention and the placebo groups.
Results: Fourteen RCTs with 971 participants (47% women) were pooled for analysis. Green tea or GTE produced a significant effect on both SBP (mean difference -1.42 mmHg, 95% confidence interval -2.47 to -0.36, P = 0.008; I = 52%, P = 0.01 for heterogeneity) and DBP (mean difference -1.25 mmHg, 95% confidence interval -2.32 to -0.19, P = 0.02; I = 74%, P < 0.001 for heterogeneity), compared with placebo. The quality of evidence across studies was low. Similar results were found in subgroup and sensitivity analyses.
Conclusion: Among overweight and obese adults, green tea or GTE supplementation is found to cause a small but significant reduction in BP. More high-quality RCTs with large sample sizes are needed to further confirm the efficacy on BP and make strong recommendations for green tea or GTE supplementation among the overweight and obese adults.
Similar articles
-
Effect of green tea supplementation on blood pressure among overweight and obese adults: a protocol for a systematic review.BMJ Open. 2014 Apr 17;4(4):e004971. doi: 10.1136/bmjopen-2014-004971. BMJ Open. 2014. PMID: 24742977 Free PMC article.
-
Long-Term Supplementation of Green Tea Extract Does Not Modify Adiposity or Bone Mineral Density in a Randomized Trial of Overweight and Obese Postmenopausal Women.J Nutr. 2016 Feb;146(2):256-64. doi: 10.3945/jn.115.219238. Epub 2015 Dec 23. J Nutr. 2016. PMID: 26701796 Free PMC article. Clinical Trial.
-
Short-term Effects of Green Tea on Blood Pressure, Endothelial Function, and Metabolic Profile in Obese Prehypertensive Women: A Crossover Randomized Clinical Trial.J Am Coll Nutr. 2017 Feb;36(2):108-115. doi: 10.1080/07315724.2016.1194236. Epub 2016 Oct 31. J Am Coll Nutr. 2017. PMID: 27797683 Clinical Trial.
-
Effect of tea on blood pressure for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials.Nutr Rev. 2015 Apr;73(4):236-46. doi: 10.1093/nutrit/nuv001. Nutr Rev. 2015. PMID: 26024546 Review.
-
[Effect of green tea or green tea extract consumption on body weight and body composition; systematic review and meta-analysis].Nutr Hosp. 2014 Mar 1;29(3):479-90. doi: 10.3305/nh.2014.29.3.7118. Nutr Hosp. 2014. PMID: 24558988 Review. Spanish.
Cited by
-
Impact of Green Tea Consumption on the Prevalence of Cardiovascular Outcomes: A Systematic Review.Cureus. 2023 Dec 1;15(12):e49775. doi: 10.7759/cureus.49775. eCollection 2023 Dec. Cureus. 2023. PMID: 38161525 Free PMC article. Review.
-
Effects of green tea catechin on the blood pressure and lipids in overweight and obese population-a meta-analysis.Heliyon. 2023 Nov 7;9(11):e21228. doi: 10.1016/j.heliyon.2023.e21228. eCollection 2023 Nov. Heliyon. 2023. PMID: 38034724 Free PMC article.
-
Oxidative Stress, Antioxidants and Hypertension.Antioxidants (Basel). 2023 Jan 27;12(2):281. doi: 10.3390/antiox12020281. Antioxidants (Basel). 2023. PMID: 36829839 Free PMC article. Review.
-
The effects of green tea supplementation on cardiovascular risk factors: A systematic review and meta-analysis.Front Nutr. 2023 Jan 10;9:1084455. doi: 10.3389/fnut.2022.1084455. eCollection 2022. Front Nutr. 2023. PMID: 36704803 Free PMC article. Review.
-
Epigallocatechin gallate (EGCG) alleviates vascular dysfunction in angiotensin II-infused hypertensive mice by modulating oxidative stress and eNOS.Sci Rep. 2022 Oct 21;12(1):17633. doi: 10.1038/s41598-022-21107-5. Sci Rep. 2022. PMID: 36271015 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical